T1	Participants 636 894	Parents of 101 children with autism who had participated in a multi-site 8-week double-blind clinical trial of risperidone were given a questionnaire at the end to elicit their perceptions of the appropriateness and acceptability of clinical trial procedures
T2	Participants 904 957	Ninety-six (95.0%) parents returned the questionnaire
T3	Participants 563 627	children with autistic disorder and severely disruptive behavior
